Genetic and epigenetic changes in nasopharyngeal carcinoma

Semin Cancer Biol. 2002 Dec;12(6):451-62. doi: 10.1016/s1044579x02000883.

Abstract

Nasopharyngeal carcinoma (NPC) is a malignancy with remarkable racial and geographic distribution. The development of this EBV-associated cancer likely involves cumulative genetic and epigenetic changes in a background of predisposed genetic and environmental factors. Genome-wide studies have unravelled multiple chromosomal abnormalities with involvement of specific oncogenes and tumour suppressor genes. Alterations of genes such as Ras association domain family 1A (RASSF1A), p16/INK4A, p14/ARF suggest that multiple cellular pathways were dysregulated in the NPC cells. Studies on the precancerous lesions revealed early genetic changes and a critical role of EBV latent infection in the development of this cancer. Based on the existing findings, a pathogenetic model for NPC is proposed.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Apoptosis
  • Cell Adhesion Molecule-1
  • Cell Adhesion Molecules
  • Chromosome Aberrations
  • DNA Methylation
  • Epstein-Barr Virus Infections / complications
  • Gene Expression Profiling
  • Genes, Tumor Suppressor
  • Humans
  • Immunoglobulins*
  • Loss of Heterozygosity
  • Membrane Proteins*
  • Nasopharyngeal Neoplasms / etiology
  • Nasopharyngeal Neoplasms / genetics*
  • Neoplasm Proteins / genetics
  • Oncogenes
  • Proteins / genetics
  • Tumor Suppressor Proteins*

Substances

  • CADM1 protein, human
  • Cell Adhesion Molecule-1
  • Cell Adhesion Molecules
  • Immunoglobulins
  • Membrane Proteins
  • Neoplasm Proteins
  • Proteins
  • RASSF1 protein, human
  • Tumor Suppressor Proteins